← Leaderboards
Han-Mou Tsai
Montefiore Medical Center (Bronx, Ny)
$2,809,267
Attributed
$2,809,267
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $339.1K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,809,267 · 2
By mechanism
R01$2,809,267 · 2
Top collaborators
No co-investigators on record.
Most similar at Montefiore Medical Center (Bronx, Ny)
Same institution · by research overlap
- David J Prezant$24,724,464
- Edward L Schwartz$6,745,000
Others in their field
Top investigators on “Von Willebrand Factor”
- Robert R Montgomery · Medical College Of Wisconsin$20,819,917
- Jose Aron Lopez · Baylor College Of Medicine$16,844,145
- David Ginsburg · University Of Michigan At Ann Arbor$14,023,276
- Zaverio M Ruggeri · Scripps Research Institute$11,965,401
- X. Long Zheng · University Of Kansas Medical Center$10,198,380
- Renhao Li · Emory University$9,914,119
Research focus
Von Willebrand FactorThrombocytopenic PurpuraClinical ResearchMetalloendopeptidasesHuman SubjectLaboratory MouseComorbidityCongenital Blood DisorderBlood ChemistryProtease InhibitorThrombosisPathologic ProcessRelapse /RecurrencePlasmapheresisLaboratory RabbitEnzyme DeficiencyDisease /Disorder EtiologyHiv InfectionsCandidate Disease GeneBlood TreatmentBaseBlood TransfusionBlood PlateletsAutoimmunity
Grant awards (12)
ADAMTS13 Deficiency in TTP$276,035
R01 · FY2008 · HL · contact PI
ADAMTS13 Deficiency in TTP$63,023
R01 · FY2008 · HL · contact PI
ADAMTS13 Deficiency in TTP$320,181
R01 · FY2007 · HL · contact PI
ADAMTS13 Deficiency in TTP$310,881
R01 · FY2006 · HL · contact PI
ADAMTS13 Deficiency in TTP$337,309
R01 · FY2005 · HL
Inhibitors of ADAMTS313 and Outcome of TTP$135,559
R01 · FY2004 · HL
VWF PROTEINASE DEFICIENCY IN TTP WITH OR WITHOUT HIV$279,219
R01 · FY2003 · HL
Inhibitors of ADAMTS313 and Outcome of TTP$134,523
R01 · FY2003 · HL
VWF PROTEINASE DEFICIENCY IN TTP WITH OR WITHOUT HIV$271,083
R01 · FY2002 · HL
Inhibitors of ADAMTS313 and Outcome of TTP$162,515
R01 · FY2002 · HL
VWF PROTEINASE DEFICIENCY IN TTP WITH OR WITHOUT HIV$263,247
R01 · FY2001 · HL
VWF PROTEINASE DEFICIENCY IN TTP WITH OR WITHOUT HIV$255,692
R01 · FY2000 · HL